Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00393419 · ClinicalTrials.gov registry record · NA

Federal Study of Adherence to Medications in the Elderly (FAME)

A NA study of Hypertension and Medication Adherence, sponsored by Walter Reed Army Medical Center.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT00393419: Completed NA study of Hypertension and Medication Adherence, sponsored by Walter Reed Army Medical Center.

NCT00393419 is a NA study of Hypertension and Medication Adherence that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00393419, a NA study of Hypertension and Medication Adherence, has completed, sponsored by Walter Reed Army Medical Center.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effect of a comprehensive pharmacy care program on medication adherence and persistence, blood pressure, and LDL cholesterol.

Interventions

  • BEHAVIORAL Comprehensive pharmacy care program

Study Locations (1)

District of Columbia

  • Walter Reed Army Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2004-06
Est. Completion 2006-08
Phase NA
Walter Reed Army Medical Center

24 total trials

What the finished NCT00393419 record still lists

NCT00393419 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive pharmacy care program is the first listed.

NCT00393419 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00393419 about?

NCT00393419 is a clinical study titled "Federal Study of Adherence to Medications in the Elderly (FAME)". The purpose of this study is to determine the effect of a comprehensive pharmacy care program on medication adherence and persistence, blood pressure, and LDL cholesterol.

What is the current status of trial NCT00393419?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2004-06. Estimated completion is 2006-08.

What conditions does trial NCT00393419 study?

This clinical trial studies the following conditions: Hypertension, Medication Adherence, Hyperlipidemia.

What interventions are being tested in trial NCT00393419?

The interventions under investigation include: Comprehensive pharmacy care program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00393419?

This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00393419 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00393419's enrollment target sits among peer trials

200 219th of 470 higher than 246 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00393419, the US trial registry maintained by the National Library of Medicine. NCT00393419 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.